ProShares Ultra Semiconductors (USD) Stock Price Today
Key Stats
- $2.95BMarket Cap
- 316,008Volume
- Leveraged / InverseSector
- $113.5352W High
- $43.1952W Low
- 28 DaysTypical Hold Time
- -Enterprise Value
- -Div Yield
- 48% Sell | 52% BuyTrading Activity
Track ProShares Ultra Semiconductors (USD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ProShares Ultra Semiconductors has traded between a low of $43.19 and a high of $113.53, highlighting its annual price range. Buy and sell ProShares Ultra Semiconductors shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About ProShares Ultra Semiconductors
USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Most Recent News
Several high-volume stocks plunge sharply amid profit-taking despite positive updates.
Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.
Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.
Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.